Viagra May Shield Heart From Blood Pressure Damage (HealthDay)
HealthDay - MONDAY, Jan. 5 (HealthDay News) --
Tests in mouse hearts show that sildenafil, the key ingredient in Viagra,
may shield hearts from damage caused by high blood pressure, a new study
Health Highlights: Jan. 3, 2009 (HealthDay)
HealthDay - Here are some of the latest health and medical news developments,
compiled by editors of
Health Highlights: Jan. 2, 2009 (HealthDay)
HealthDay - Here are some of the latest health and medical news developments,
compiled by editors of
Cough medicine ingredient may treat prostate cancer (Reuters)
Reuters - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in
Degarelix Approved for Advanced Prostate Cancer (HealthDay)
HealthDay - MONDAY, Dec. 29 (HealthDay News) -- The injected drug degarelix
has been approved by the U.S. Food and Drug Administration to treat
advanced prostate
FDA approves new prostate cancer drug (AP)
AP - Federal regulators on Monday said they have approved the first new drug to treat prostate cancer in four
Health Tip: Why You May Have Erectile Dysfunction (HealthDay)
HealthDay - (HealthDay News) -- Erectile dysfunction occurs when a man can't
achieve or maintain an erection during
Men who live alone fall short on prostate screening (Reuters)
Reuters - Men at higher-than-average risk of prostate cancer are more likely to seek regular screening if they are married or live with a significant other, a new study
Radiation Plus Hormone Therapy Cuts Prostate Cancer Deaths (HealthDay)
HealthDay - MONDAY, Dec. 15 (HealthDay News) -- Men with locally advanced prostate
cancer -- cancer that has spread beyond the wall of the prostate gland --
who undergo radiation plus long-term hormone treatment cut their risk of
dying in half, a new study has
Combo treatment for prostate cancer cuts deaths (AP)
AP - Treating advanced prostate cancer with radiation and hormone-blocking drugs cut the death rate in half in a study of Scandinavian men, researchers report. In the United States, the combination has been standard care since the 1990s. But in Europe, many doctors have avoided the combo treatment and used hormone drugs alone, thinking the pair would be too harsh for most